Founded in 2015 by two scientists from Merck Pharmaceuticals — Stephen Gallagher, 47, and Alastair Hill, 42 — this Hertfordshire firm develops software to support new drug research. Its software is cloud-based, so scientists working from home continue to have full access to the company’s data and tools, which it claims can analyse a trillion strands of DNA a second. In 2018, profits reached £4.2m, with growth fuelled by funding received from Scottish Equity Partners the previous year.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.